FierceBiotech ٩ ديسمبر ٢٠٢٥ ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
FierceBiotech ٨ ديسمبر ٢٠٢٥ With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec
FierceBiotech ٨ ديسمبر ٢٠٢٥ Dr. Reddy's pens $370M pact for rights to Immutep's phase 3-stage immunotherapy in certain markets
FierceBiotech ٨ ديسمبر ٢٠٢٥ AbbVie hands back phase 1 duties for chronic inflammation drug to partner OSE
FierceBiotech ٧ ديسمبر ٢٠٢٥ ASH: Anito-cel strengthens best-in-class potential as Gilead's Kite preps for launch
FierceBiotech ٧ ديسمبر ٢٠٢٥ ASH: Star antibody sparkles in preview of potential phase 3 bleeding disease success
FierceBiotech ٦ ديسمبر ٢٠٢٥ ‘Market’s thinking is backwards’: FDA’s 1-trial approval plan would boost R&D spend, Jefferies says
FierceBiotech ٥ ديسمبر ٢٠٢٥ Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M
FierceBiotech ٥ ديسمبر ٢٠٢٥ Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data
FierceBiotech ٥ ديسمبر ٢٠٢٥ 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out
FierceBiotech ٥ ديسمبر ٢٠٢٥ How AI and real-world evidence are powering smarter decisions across the drug and device development lifecycle